62 research outputs found
L’uso della tecnologia DEM nella documentazione archeologica. Alcune applicazioni in casi di scavo stratigrafico e nello studio dell’edilizia storica
No full textThis paper describes a procedure of archaeological interpretation and representation based on DEM technology. Through different contexts of application the aim is to describe the potential of this procedure, useful for recreating all the stratigraphic complexity of an archaeological site. After an introduction and a short history of studies about the use of DEM in archaeological documentation, the Author illustrates two examples of archaeological excavation and two of archaeology of architecture. The first case study is the Castle of Castelpizigolo (Toano, RE): the DEM documentation was used for the production of automatic profile lines of every archaeological stratification. A similar result was obtained in the documentation of the second archaeological context, the site of Capo Don (Riva Ligure, IM). The subject of this investigation was a fireplace dating from Late Antiquity to the early medieval period. The second part was focused on the use of DEM in the archaeological analysis of buildings. A preliminary investigation was focused on an example of household architecture from the island of Rab (Croatia). The DEM was used for the interpretation of the origins of some architectural instabilities, caused by stratigraphic changes which occurred in the original building. The last case study was the rural church of S. Giusto in Marlia (LU), where DEM analysis gave a new interpretation about the archaeological evolution of this building. The procedure described in this paper is an innovative method for producing a faster and more accurate archaeological documentation and for giving a new archaeological tool for the stratigraphic interpretation of historical buildings
Uso de somatotropina recombinante bovina no período de transição e seu impacto no metabolismo e na incidência de doenças no periparto
No full textOrientador : Prof. Dr. Rodrigo de AlmeidaDissertação (mestrado) - Universidade Federal do Paraná, Setor de Ciências Agrárias, Programa de Pós-Graduação em Zootecnia. Defesa : Curitiba, 29/05/2017Inclui referênciasResumo: O período de transição em vacas leiteiras se apresenta como um dos principais pontos críticos no processo de produção de leite. Falhas imunológicas neste período decorrentes da baixa condição imunitária no periparto somadas a inabilidade do animal em manter o consumo no mesmo período acabam determinando problemas metabólicos, sanitários, produtivos e reprodutivos que muitas vezes acabam desencadeando o descarte precoce de animais no início do processo de produção. Várias estratégias ao longo dos anos têm sido adotadas para minimizar estes efeitos, sendo que o uso de somatotropina recombinante bovina como fator modulador da manutenção da resposta imune ao parto têm se configurado uma estratégia promissora. O uso de somatotropina recombinante bovina durante a lactação, seus efeitos somatogênicos e o de partição de nutrientes, com finalidade de promover o aumento da produção leiteira já são bem fundamentados. Apesar dos mecanismos envolvidos na regulação da ingestão de alimentos durante o período de transição ainda não estarem completamente elucidados, o deslocamento do eixo somatotrópico tem sido apontado como um dos principais fatores para esta aparente falha entre demanda e fornecimento energético. Foram avaliadas duas diferentes estratégias de suplementação da somatotropina recombinante bovina com um grupo controle adicional em 692 vacas da raça holandesa pertencentes a dois rebanhos leiteiros comerciais, durante os meses de Setembro de 2016 a Março de 2017. Os animais foram avaliados para inclusão e balanceamento dos grupos tratamentos observando o número de lactações, o escore de condição corporal e o peso individual dos animais, sendo divididos a partir daí em três diferentes grupos; Sendo o Grupo 1 suplementado com Salina no pré e no pós-parto; Grupo 2 suplementado com somatotropina no pré-parto e no dia do parto; E o grupo 3 suplementado com somatotropina no pré-parto e no pós-parto. As dietas das duas propriedades no préparto e no pós-parto foram coletadas e analisadas, assim como foi checado o pH urinário dos animais durante o pré-parto. Os animais tiveram amostras de sangue coletadas no dia do parto para avalição de albumina, ácidos graxos não esterificados (AGNE), aspartato aminotransferase (AST), cálcio total, colesterol, gamaglutamiltransferase (GGT), Triglicerídeos e VLDL, e nos dias 6 e 13 do pós parto para avaliação de beta-hidroxibutirato (BHBA).Todos os animais foram avaliados nos 30 dias iniciais da lactação paraa identificação da prevalência de cetose, cetose clínica, metrite, retenção de anexos fetais, deslocamento de abomaso e descarte. Os animais suplementados com somatotropina no pré-parto apresentaram valores de perfil metabólico e de incidência de doenças similar ao grupo controle. Já o grupo suplementado no pré-parto e no pós-parto apresentou um aumento na mobilização de reservas corporais muito acentuado, com aumento da prevalência de cetose, no número de animais tratados para cetose clínica e nos casos de metrite e deslocamento de abomaso. Baseado nestes resultados a aplicação de somatotropina recombinante bovina no pré-parto e pós-parto seria desaconselhada e somente no pré-parto necessita dos dados de produção e reprodução para ser recomendada. Palavras-chave: Imunologia. Periparto. Vacas leiteiras.Abstract: The transition period in dairy cows is one of the most critical points in the milk production process. Immunological failures in this period due to the low immune status in the peripartum combined with the animal's inability to maintain consumption during the same period leads to metabolic, sanitary, productive and reproductive problems that often end up triggering the early disposal of animals at the beginning of the production process. Several strategies over the years have been adopted to minimize these effects, and the use of recombinant bovine somatotropin as a modulator of the maintenance of the immune response to childbirth has been configured a promising strategy. The use of recombinant bovine somatotropin during lactation, its somatogenic effects and nutrient partitioning, in order to promote the increase of milk production are already studed. Although the mechanisms involved in the regulation of food intake during the transitional period are still not completely elucidated, the displacement of the somatotropic axis has been pointed out as one of the main factors for this apparent lack of demand and energy supply. Two different strategies of bovine recombinant somatotropin supplementation with an additional control group were evaluated in 692 Holstein cows belonging to two commercial dairy herds from September 2016 to March 2017. The animals were evaluated for inclusion and balanced on the treatments groups observing the number of lactations, the body condition score and the individual weight of the animals, being divided from there into three different groups; Group 1 was supplemented with Saline in the pre and postpartum period; Group 2 supplemented with somatotropin in the prepartum and on the day of calving; And group 3 supplemented with somatotropin in prepartum and postpartum. The prepartum and postpartum diets of the two properties were collected and analyzed, as well as the urinary pH of the animals during prepartum. The animals had blood samples collected on the day of calving to evaluate albumin, non-esterified fatty acids (NEFA), aspartate aminotransferase (AST), total calcium, cholesterol, gamma-glutamyltransferase (GGT), triglycerides and VLDL, and on days 6 and 13 postpartum for beta-hydroxybutyrate (BHBA) evaluation. All animals were evaluated in the initial 30 days of lactation to identify the prevalence of ketosis, clinical ketosis, metritis, retention of fetal attachments, abomasal displacement and culling._ The animals supplemented with somatotropin in the prepartum presented values of metabolic profile and incidence of diseases similar to the control group. The pre-partum and postpartum supplementation group showed a marked increase in fat mobilization, with an increase in the prevalence of ketosis, in the number of animals treated for clinical ketosis, and in the cases of metritis and abomasal displacement. Based on these results the application of recombinant bovine somatotropin in prepartum and postpartum would be discouraged and only in pre-partum it needs production and reproduction data to be recommended. Keywords: Immunology. Peripartum. Dairy cows
Performance management systems and regulatory compliance in the banking industry –A case study of a Swedish niche bank
No full textBackground and Problem: The regulations imposed after the financial crisis have created an opportunity for management accounting research. One area within management accounting is performance management which involves; identifying, measuring and developing the perfor-mance of individuals, and aligning this performance with organizational goals. To study this area, a framework was created by Ferreira and Otley (2009), called the performance management systems (PMSs) framework. According to researchers there is a gap in studying the design and use of PMSs in banks and financial institutions. However, a recent study about PMSs in Swedish banks was conducted by Lundberg (2013). It showed that banks only to a limited extent adapted their PMSs in response to the regulatory changes, and the author suggests that more research is needed.
Aim of study: This study investigates how PMSs change due to three banking regulations. Also, what banks can do to increase performance by embracing the regulations is studied.
Methodology: This study is based on a case study of a Swedish niche bank, which was chosen because niche banks were prior to Basel II not believed to be able to use their own risk models, something that the case company does. Interviews with key employees were the primary source of information for the empirical findings.
Analysis and Conclusion: This study shows that banking regulations do have an effect on PMSs. However, a lack of coherence has limited the spread of the effect. This limited effect depends on poor coherence between the PMSs, which results in that the PMSs will not be uti-lized to their full capacity. The limited effect also depends on decoupling of performance management from risk management
Consensus statement for the management of Acute Coronary Syndromes and the COVID-19 pandemic
No full textFil: Muntaner, Juan A. Universidad Nacional de Tucumán. Facultad de Medicina. Centro Modelo de Cardiología; Argentina.Fil: Muntaner, Juan A. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Ramos, Hugo R. Universidad Nacional de Córdoba. Facultad de Ciencias Médicas; Argentina.Fil: Ramos, Hugo R. Instituto Modelo de Cardiología; Argentina.Fil: Ramos, Hugo R. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Macín, Stella M. Universidad Nacional del Nordeste. Facultad de Medicina; Argentina.Fil: Macín, Stella M. Instituto de Cardiología de Corrientes; Argentina.Fil: Macín, Stella M. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Bono, Julio O. Universidad Católica de Córdoba. Facultad de Medicina; Argentina.Fil: Bono, Julio O. Sanatorio Allende Nueva Córdoba, Argentina.Fil: Bono, Julio O. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Zapata, Gerardo O. Universidad Nacional de Rosario. Facultad de Medicina; Argentina.Fil: Zapata, Gerardo O. Universidad Nacional de Rosario. Facultad de Medicina; Argentina.Fil: Zapata, Gerardo O. Instituto Cardiovascular de Rosario; Argentina.Fil: Zapata, Gerardo O. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Zoni, Rodrigo. Instituto de Cardiología de Corrientes; Argentina.Fil: Zoni, Rodrigo. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Atencio, Lorena. Instituto del Corazón San Rafael, Mendoza; Argentina.Fil: Atencio, Lorena. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Fernández Cid, Gerardo. Ex Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires; Argentina.Fil: Fernández Cid, Gerardo. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Barcudi, Raúl J. Universidad Católica de Córdoba. Facultad de Medicina; Argentina.Fil: Barcudi, Raúl J. Clínica Universitaria Reina Fabiola, Córdoba; Argentina.Fil: Barcudi, Raúl J. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Paterlini, Gustavo A. Universidad Nacional de Tucumán. Facultad de Medicina; Argentina.Fil: Paterlini, Gustavo A. Hospital Zenón Santillán, Tucumán; Argentina.Fil: Paterlini, Gustavo A. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Suasnabar, Ramón. Nueva Clínica Chacabuco, Tandil, Buenos Aires; Argentina.Fil: Suasnabar, Ramón. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Mauro, Daniel O. Instituto del Corazón San Rafael, San Rafael, Mendoza; ArgentinaFil: Mauro, Daniel O. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Moisés Azize, Guillermo. Hospital Córdoba; Argentina.Fil: Moisés Azize, Guillermo. Sanatorio Aconcagua, Córdoba; Argentina.Fil: Moisés Azize, Guillermo. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Rengel, Esteban. Hospital General Lamadrid, Monteros, Tucumán; Argentina.Fil: Rengel, Esteban. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Amoroso, Alejandro. Hospital San Bernardo, Salta; Argentina.Fil: Amoroso, Alejandro. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Los servicios de cardiología de Argentina deben estar preparados para manejar pacientes con patología cardíaca aguda en el contexto de la pandemia del coronavirus (COVID-19)1. Los pacientes con infección COVID-19 que tengan manifestaciones más graves serán derivados a la unidad de cuidados intensivos y aquellos con síntomas leves a moderados serán manejados en sala de medicina general. Cuando ambas áreas estén completamente llenas, comenzaremos a recibir pacientes en la unidad de cardiología.
El síndrome coronario agudo (SCA) no escapa a esta realidad. El personal médico, enfermeros, técnicos deben conocer la problemática, recibir capacitación acerca de cómo protegerse y prevenir la infección en sus pacientes, cuándo y cómo aislar a los mismos una vez infectados, así como conocer el equipo de protección que se debe utilizar.
Por otro lado toda situación de estrés social como el que está creando esta pandemia en la población argentina, produce un incremento de eventos y muerte cardiovascular2
La asociación entre la enfermedad respiratoria viral y el riesgo de enfermedad cardiovascular posterior ha sido bien establecida; infecciones agudas, particularmente influenza, se han relacionado a infarto de miocardio y descompensación de insuficiencia cardíaca.
Pacientes con infarto agudo de miocardio (IAM) acompañado de fiebre, especialmente con síntomas respiratorios, primero deberían ser derivados a un SECTOR para EVALUACIÓN DEL CUADRO. El sector que determine cada institución, dispondrá de un lugar en UCO-UTI y/o cardiología.publishedVersionFil: Muntaner, Juan A. Universidad Nacional de Tucumán. Facultad de Medicina. Centro Modelo de Cardiología; Argentina.Fil: Muntaner, Juan A. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Ramos, Hugo R. Universidad Nacional de Córdoba. Facultad de Ciencias Médicas; Argentina.Fil: Ramos, Hugo R. Instituto Modelo de Cardiología; Argentina.Fil: Ramos, Hugo R. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Macín, Stella M. Universidad Nacional del Nordeste. Facultad de Medicina; Argentina.Fil: Macín, Stella M. Instituto de Cardiología de Corrientes; Argentina.Fil: Macín, Stella M. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Bono, Julio O. Universidad Católica de Córdoba. Facultad de Medicina; Argentina.Fil: Bono, Julio O. Sanatorio Allende Nueva Córdoba, Argentina.Fil: Bono, Julio O. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Zapata, Gerardo O. Universidad Nacional de Rosario. Facultad de Medicina; Argentina.Fil: Zapata, Gerardo O. Universidad Nacional de Rosario. Facultad de Medicina; Argentina.Fil: Zapata, Gerardo O. Instituto Cardiovascular de Rosario; Argentina.Fil: Zapata, Gerardo O. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Zoni, Rodrigo. Instituto de Cardiología de Corrientes; Argentina.Fil: Zoni, Rodrigo. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Atencio, Lorena. Instituto del Corazón San Rafael, Mendoza; Argentina.Fil: Atencio, Lorena. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Fernández Cid, Gerardo. Ex Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires; Argentina.Fil: Fernández Cid, Gerardo. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Barcudi, Raúl J. Universidad Católica de Córdoba. Facultad de Medicina; Argentina.Fil: Barcudi, Raúl J. Clínica Universitaria Reina Fabiola, Córdoba; Argentina.Fil: Barcudi, Raúl J. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Paterlini, Gustavo A. Universidad Nacional de Tucumán. Facultad de Medicina; Argentina.Fil: Paterlini, Gustavo A. Hospital Zenón Santillán, Tucumán; Argentina.Fil: Paterlini, Gustavo A. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Suasnabar, Ramón. Nueva Clínica Chacabuco, Tandil, Buenos Aires; Argentina.Fil: Suasnabar, Ramón. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Mauro, Daniel O. Instituto del Corazón San Rafael, San Rafael, Mendoza; ArgentinaFil: Mauro, Daniel O. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Moisés Azize, Guillermo. Hospital Córdoba; Argentina.Fil: Moisés Azize, Guillermo. Sanatorio Aconcagua, Córdoba; Argentina.Fil: Moisés Azize, Guillermo. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Rengel, Esteban. Hospital General Lamadrid, Monteros, Tucumán; Argentina.Fil: Rengel, Esteban. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina.Fil: Amoroso, Alejandro. Hospital San Bernardo, Salta; Argentina.Fil: Amoroso, Alejandro. Federación Argentina de Cardiología. Comité de Cardiopatía Isquémica; Argentina
Supplemental Material - SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion
No full textSupplemental Material for SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion by Giuseppe De Luca, MD, PhD, Magdy Algowhary, Berat Uguz, Dinaldo C Oliveira, Vladimir Ganyukov, Zan Zimbakov, Miha Cercek, Lisette Okkels Jensen, Poay Huan Loh, Lucian Calmac, Gerard Roura i Ferrer, Alexandre Quadros, Marek Milewski, Fortunato Scotto Di Uccio, Clemens von Birgelen, Francesco Versaci, Jurrien Ten Berg, Gianni Casella, Aaron Wong Sung Lung, Petr Kala, José Luis Díez Gil, Xavier Carrillo, Maurits Dirksen, Victor M. Becerra-Munoz, Michael Kang-yin Lee, Dafsah Arifa Juzar, Rodrigo de Moura Joaquim, Ciro De Simone, Davor Milicic, Periklis Davlouros, Nikola Bakraceski, Filippo Zilio, Luca Donazzan, Adriaan Kraaijeveld, Gennaro Galasso, Lux Arpad, Marinucci Lucia, Guiducci Vincenzo, Maurizio Menichelli, Alessandra Scoccia, Aylin Hatice Yamac, Kadir Ugur Mert, Xacobe Flores Rios, Tomas Kovarnik, Michal Kidawa, Josè Moreu, Vincent Flavien, Enrico Fabris, Iñigo Lozano Martínez-Luengas, Marco Boccalatte, Francisco Bosa Ojeda, Carlos Arellano-Serrano, Gianluca Caiazzo, Giuseppe Cirrincione, Hsien-Li Kao, Juan Sanchis Forés, Luigi Vignali, Helder Pereira, Stephane Manzo-Silbermann, Santiago Ordoñez, Alev Arat Özkan, Bruno Scheller, Heidi Lehtola, Rui Teles, Christos Mantis, Ylitalo Antti, João António Brum Silveira, Rodrigo Zoni, Ivan Bessonov, Stefano Savonitto, George Kochiadakis, Dimitrios Alexopoulos, Carlos E Uribe, John Kanakakis, Benjamin Faurie, Gabriele Gabrielli, Alejandro Gutierrez Barrios, Juan Pablo Bachini, Alex Rocha, Frankie Chor-Cheung Tam, Alfredo Rodriguez, Antonia Anna Lukito, Anne Bellemain-Appaix, Gustavo Pessah, Giuliana Cortese, Guido Parodi, MD, Mohammed Abed Burgadha, Elvin Kedhi, Pablo Lamelas, Harry Suryapranata, Matteo Nardin, Monica Verdoia in Angiology</p
Integrating Critical Incidents in the Language Classroom
No full textOver the course of the years, educators around the globe have come to agree that communication in a foreign language requires more than just linguistic skills. Teaching skills such as critical thinking and cultural awareness have become essential to nurture intercultural speakers. However, how can said skills be integrated in the language classroom? This paper aims to offer insights into the use of the Critical Incident Technique (CIT), a narration-based activity often used in intercultural communication classes and workshops. The paper will first explain the origin of CIT and its importance in the language classroom. Subsequently, the author will explain how to create an original critical incident, and finally how to effectively conduct the activity in the classroom. This paper aims to be a practical guide to the creation and appropriate use of CIT, ultimately assisting teachers on how to nurture intercultural speakers
Documento de Consenso sobre terapia antitrombótica en enfermedad coronaria del Comité de Cardiopatía Isquémica de la Federación Argentina de Cardiología
No full textLos pacientes con cardiopatía isquémica se presentan en diferentes escenarios clínicos de la enfermedad
coronaria, desde los síndromes coronarios agudos (con y sin elevación del segmento ST), síndromes coronarios crónicos y situaciones especiales definidas por la co-existencia de ciertos factores de riesgo (diabetes mellitus, enfermedad renal crónica, fibrilación auricular y otras), los cuales pueden requerir de diferentes pautas (o protocolos) de terapia antitrombótica. El objetivo principal de la terapia antitrombótica es el
reducir los eventos isquémicos sin aumentar los riesgos, primordialmente complicaciones hemorrágicas,
asociadas a este tipo de intervención. El objetivo de este artículo es ofrecer una revisión basada en la evidencia más recientes teniendo en cuenta las diferentes situaciones clínicas, así como un cuidadoso análisis del balance de beneficios y riesgos (reducción de eventos y complicaciones hemorrágicas, respectivamente) asociado con la terapia antitrombótica de los pacientes con enfermedad cardiovascular.Fil: Barcudi, Raúl Jesús. Universidad Católica de Córdoba. Clínica Universitaria Reina Fabiola; ArgentinaFil: Bono, Julio. Sanatorio Allende; ArgentinaFil: Ramos, Hugo Roberto. Universidad Nacional de Córdoba; ArgentinaFil: Quiroga Castro, Walter. Instituto Modelo de Cardiología; ArgentinaFil: Muntaner, Juan. Universidad Nacional de Tucumán; ArgentinaFil: Macín, Stella. Universidad Nacional del Nordeste; ArgentinaFil: Zapata, Gerardo. Instituto Cardiovascular de Rosario; ArgentinaFil: Meiriño, Alejandro. Instituto Cardiovascular de Rosario; ArgentinaFil: Hominal, Miguel. Sanatorio Diagnóstico; ArgentinaFil: Mauro, Daniel. Instituto del Corazón San Rafael; ArgentinaFil: Atencio, Lorena. Instituto del Corazón San Rafael; ArgentinaFil: Fernández Murga, Arturo. Instituto de Cardiología; ArgentinaFil: Amoroso, Alejandro. Hospital San Bernardo; ArgentinaFil: Rengel, Esteban. Instituto de Cardiología; ArgentinaFil: Hasbani, Eduardo. Universidad Nacional de Tucumán; ArgentinaFil: Luciardi, Héctor. Universidad Nacional de Tucumán; ArgentinaFil: Zoni, César Rodrigo. Instituto de Cardiología JF Cabral; ArgentinaFil: Onocko, Mariela. Instituto de Cardiología JF Cabral; ArgentinaFil: Caruso, Orlando. Hospital Central de Mendoza; Argentin
Approach to the arrangement of pedestrian areas in Zagreb
No full textAutor istražuje pješačke zone koje se kao gradski prostori transformiraju u složenim oblikovnim, tehničkim, socijalnim, ekonomskim i drugim funkcijama prisutnim u planersko-projektantskim i upravnim zahvatima te u spontanim procesima stanovništva. Promjene u zagrebačkoj pješačkoj zoni tijekom dvadesetak godina upućuju na jačanje simboličkih potreba uređenja središnjih područja grada, utjecaje komercijalizacije, shvaćanja granica javnoga i privatnoga, obilježja urbanoga i ruralnoga itd.The author analyzes pedestrian areas, which envolve in cities through the complex interaction of aesthetic, thecnical, social, economic and otheer factors in town-plans and administrative procedures, and through spontaneous processes that take place in population. Changes in Zagreb pedestrian areas during the last twenty years indicate the increasing satisfaction of symbolic needs for the arrangement of central city areas, the influence of commercialization, changing attitudes to the boundary between the public and the private, urban and rural features, and so on
THE PROTECTION OF THE CULTURAL HERITAGE ON THE DEEP SEABED IN INTERNATIONAL LAW – CAN THE TITANIC BE SAVED?
No full textRadom se želi pokazati da suvremeno međunarodno pravo nudi rješenja kada je riječ o zaštiti kulturne baštine u morskim prostorima izvan nacionalne jurisdikcije, tj. u Zoni međunarodnog podmorja. Pritom se daje poseban osvrt na pitanje zaštite olupine putničkog parobroda “Titanic” kao kulturnog dobra od značenja za cijelo čovječanstvo. U prvom dijelu rada analiziraju se međunarodnopravna pravila primjenjiva na zaštitu i očuvanje kulturnih dobara u Zoni. Analiza kreće od Konvencije UN-a o pravu mora, kojom pitanje zaštite podvodne kulturne baštine nije cjelovito uređeno. Rad se zatim detaljnije bavi međunarodnopravnim mehanizmima koje je predvidjela Konvencija UNESCO-a o zaštiti podvodne kulturne baštine. Naposljetku se razmatra i mogućnost primjene režima zaštite prema Konvenciji UNESCO-a o zaštiti svjetske kulturne i prirodne baštine. Drugi dio rada posvećen je međunarodnopravnoj situaciji glede zaštite olupine “Titanica”, gdje se, pored analize najvažnijih odredaba posebnog Sporazuma glede zaštite olupine “Titanica” iz 2003. koji još nije na snazi, raspravlja o izgledima primjene univerzalnih konvencija razmatranih u prvom dijelu rada te se nastoji dati procjena može li se predviđenim mehanizmima osigurati efikasna zaštita tog vrijednog kulturnog dobra.The paper aims to demonstrate that contemporary international law has solutions to offer when it comes to protecting the cultural heritage in maritime areas beyond national jurisdicti- on, i.e. in the International Seabed Area. In this context, the author also specifically considers issues regarding the protection of RMS Titanic’s wreck, as a cultural heritage site significant to the whole of humankind. In the first part, the paper analyses the rules of international law applicable to the protection and preservation of cultural objects in the International Seabed Area. The analysis commences with the UN Convention on the Law of the Sea, which only partially regulated the protection of the underwater cultural heritage. In addition, the paper researches in detail into the international legal mechanisms as provided for by the UNESCO Convention on the Protection of the Underwater Cultural Heritage. Finally, the author exa- mines the possibility of applying the protection regime according to the UNESCO Convention concerning the Protection of the World Cultural and Natural Heritage. The second part of the paper focuses on the international legal situation regarding the protection of Titanic’s wreck. Besides analysing the most important provisions of the special 2003 Agreement concerning the Shipwrecked Vessel RMS Titanic, which is not yet in force, the author reviews the pros- pects of applying the universal conventions discussed in the first part of the paper and also seeks to assess the effectiveness of the mechanisms at hand in assuring the protection of this valuable cultural object
- …
